Journal
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
Volume 87, Issue 1, Pages 1-18Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejpb.2014.02.005
Keywords
Lipid nanoparticles; Solid lipid nanoparticles; Nanostructured lipid carriers; Cytotoxicity; Genotoxicity; Oxidative stress; Blood compatibility; In vitro studies
Categories
Funding
- Portuguese Science and Technology Foundation (FCT) [SFRH/BD/60552/2009, PEst-OE/EQB/LA0023/2011]
- European Union Funds (FEDER/COMPETE)
- national funds (FCT) [FCOMP-01-0124-FEDER-022696]
- [PEst-C/AGR/UI4033/2011]
- Fundação para a Ciência e a Tecnologia [SFRH/BD/60552/2009, PEst-C/AGR/UI4033/2011] Funding Source: FCT
Ask authors/readers for more resources
Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) were developed as alternative to other colloidal carriers. They were designed to overcome lipid nanoemulsions and liposomes in stability and ability to control the release of an encapsulated substance, and at the same time to be better tolerated than polymeric nanoparticles. Since the patenting of SLN discovery, large amount of data became available on the behaviour of these systems in vitro. SLN/NLC have many prerequisites to be a well tolerated carrier - the currently available data seem to confirm it, but there are also some contradictory results. In this review, we collected the available data from cytotoxicity, oxidative stress and hemocompatibility studies in vitro and analysed their outcomes. We also provide a summary of the available data in a form of reference table. (C) 2014 Elsevier B.V. All rights reserved.
Authors
Anonymous
Reviews
Recommended
No Data Available